Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals
- 1 May 2001
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 7 (5) , 267-272
- https://doi.org/10.1046/j.1198-743x.2001.00256.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Clinical Isolate of Vancomycin-Heterointermediate Staphylococcus aureus Susceptible to Methicillin and In Vitro Selection of a Vancomycin-Resistant DerivativeAntimicrobial Agents and Chemotherapy, 2001
- Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Dusseldorf areaJournal of Antimicrobial Chemotherapy, 1999
- Vancomycin in surgical infections due to meticillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycinThe Lancet, 1999
- The Development of Vancomycin Resistance in a Patient with Methicillin-ResistantStaphylococcus aureusInfectionNew England Journal of Medicine, 1999
- Emergence of Vancomycin Resistance inStaphylococcus aureusNew England Journal of Medicine, 1999
- Reduced susceptibility to teicoplanin in a methicillin-resistant strain of Staphylococcus aureus.Journal of Antimicrobial Chemotherapy, 1998
- First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospitalThe Lancet, 1998
- Vancomycin-resistant Staphylococcus aureusThe Lancet, 1998
- Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinThe Lancet, 1997
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997